Moderna
MRNA
#1188
Rank
A$24.24 B
Marketcap
$63.00
Share price
-0.43%
Change (1 day)
-53.03%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$0.15 B11.81%
2023A$0.13 B-50.15%
2022A$0.27 B-85.7%
2021A$1.90 B158.2%
2020A$0.73 B369.18%
2019A$0.15 B1011.49%
2018A$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$0.78 MA$6.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$24.78 MA$98.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.09 MA$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.32 MA$39.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$86.4 MA$0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.39 MA$9.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$81.31 MA$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA